Preoperative cardiac evaluation of lung resection candidates

Thoracic Surgery Clinics
Steven L Cohn

Abstract

Patients who have lung cancer typically have both pulmonary and cardiac disease as a result of cigarette smoking and are potentially at increased risk for perioperative cardiopulmonary complications. Knowledge of risk factors and a careful preoperative assessment will help the medical team stratify the patient's level of risk and employ measures to minimize surgical risk. The available literature specific to cardiac risk and lung cancer surgery is minimal, but the general principles of preoperative cardiac risk evaluation and perioperative management have been reviewed. When considering cardiac testing and interventions, the medical consultant must remember that surgery is the treatment of choice for non-small cell lung cancer and must avoid any excessive delay that might compromise the patient's chance of a surgical cure.

References

Oct 20, 1977·The New England Journal of Medicine·L GoldmanE E Slater
Apr 1, 1992·The Annals of Thoracic Surgery·J von KnorringO Lindfors
Nov 1, 1986·Archives of Internal Medicine·A S DetskyJ R Hilliard
Jan 1, 1994·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A TerziN Ivic
Oct 1, 1994·The Annals of Thoracic Surgery·D L MillerH V Schaff
Jan 1, 1994·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·P ThomasP Fuentes
Aug 1, 1996·The Annals of Thoracic Surgery·V RaoG T Christakis
Aug 15, 1997·Annals of Internal Medicine·V A Palda, A S Detsky
Aug 1, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·M H DantonG Campalani
May 20, 1999·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·M LickerA Spiliopoulos
Apr 12, 2000·Journal of the American College of Cardiology·G L KałuzaA E Raizner
Jul 10, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Paola CiriacoPiero Zannini
Dec 21, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·O BirimA J J C Bogers
Dec 21, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Mark K Ferguson, Amy E Durkin
Jun 28, 2003·The American Journal of Medicine·Duminda N WijeysunderaW Scott Beattie
Jul 24, 2003·Journal of the American College of Cardiology·Stephanie H WilsonPeter B Berger
Apr 28, 2004·Journal of Vascular Surgery·Anai E S DurazzoBruno Caramelli
Jul 28, 2004·Anesthesiology·Arthur W WallaceDavid Kardatzke
Dec 31, 2004·The New England Journal of Medicine·Edward O McFallsWilliam G Henderson
Feb 22, 2005·The American Journal of Cardiology·Olaf SchoutenDon Poldermans
Jul 29, 2005·The New England Journal of Medicine·Peter K LindenauerEvan M Benjamin
Sep 15, 2005·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Ozcan BirimAd J J C Bogers
Oct 8, 2005·BMJ : British Medical Journal·Donald RedelmeierAlexander Kopp
Apr 19, 2006·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Efficacy Assessment Subcommittee of the American College of Physicians
Sep 5, 2006·Journal of the American College of Cardiology·Don PoldermansUNKNOWN Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group
Sep 26, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Pierre-Yves BrichonHans-Beat Ris
Jun 15, 2007·JAMA : the Journal of the American Medical Association·Wen-Chih WuPeter D Friedmann
Jul 11, 2007·Circulation·Alexander KulierUNKNOWN Ischemia Research and Education Foundation
Jul 17, 2007·The American Journal of Cardiology·Olaf SchoutenDon Poldermans
Jul 24, 2007·The Annals of Thoracic Surgery·Micha C J SchoenmakersHenry A van Swieten
Aug 3, 2007·Interactive Cardiovascular and Thoracic Surgery·Vivek ShrivastavaGraham Morritt

❮ Previous
Next ❯

Citations

Jun 22, 2011·Revista da Associação Médica Brasileira·Eduardo Oliveira FernandesLuis Carlos Correa da Silva
Sep 4, 2010·Seminars in Thoracic and Cardiovascular Surgery·Alessandro Brunelli
Feb 3, 2011·JRSM Short Reports·Sujatha KesavanGianni Angelini
Jan 21, 2012·The Korean Journal of Thoracic and Cardiovascular Surgery·Chang Young LeeKyung Young Chung
Apr 22, 2016·Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery·Kimberly MaciolekHusam H Balkhy
May 21, 2020·BMC Anesthesiology·Ricardo B Uchoa, Bruno Caramelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.